Myers Bigel Sibley & Sajovec, PA
Deazapurines and uses thereof
The present invention provides compounds having formula (I), wherein R1, R2, R3 and n are as described generally and in classes and subclasses herein, and additionally provides pharmaceutical compositions thereof, and methods for the use thereof in the treatment of inflammatory or autoimmune and proliferative disorders and as inhibitors of cell adhesion molecule expression and inflammatory cytokine signal transduction generally
Eisai Co., Ltd.
A A A A A A A A A A A A A A A A A A A A C A A A
A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61P A61K A61P A61P A61P C07D A61P A61P A61P
inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional inventional
Bruce Boris M. Fabian Yimin Wanjun Kouichi Mark Kenzo Motohiro Toshihiko Jane Lynda Seiichi Marc Hiromitsu Heather A. Ieharu Ye Norihito Yan (Janet) Xiang-Yi André
DeCosta Seletsky Gusovsky Jiang Zheng Kikuchi Spyvee Muramoto Soejima Kaneko Daun Tremblay Kobayashi Pesant Yokohama Davis Hishinuma Yao Ohi Zhao Li Lescarbeau